nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLCO1A2—Chlorambucil—testicular cancer	0.109	0.135	CbGbCtD
Quinidine—SLC22A5—Dactinomycin—testicular cancer	0.0557	0.0691	CbGbCtD
Quinidine—ABCB11—Vinblastine—testicular cancer	0.0517	0.0641	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0342	0.0424	CbGbCtD
Quinidine—CYP3A7—Ifosfamide—testicular cancer	0.0342	0.0424	CbGbCtD
Quinidine—SLC22A2—Vinblastine—testicular cancer	0.0333	0.0413	CbGbCtD
Quinidine—CYP2B6—Ifosfamide—testicular cancer	0.0326	0.0404	CbGbCtD
Quinidine—ABCB11—Doxorubicin—testicular cancer	0.0318	0.0394	CbGbCtD
Quinidine—SLC22A2—Cisplatin—testicular cancer	0.0305	0.0378	CbGbCtD
Quinidine—ABCC2—Carboplatin—testicular cancer	0.0292	0.0361	CbGbCtD
Quinidine—ABCC2—Vinblastine—testicular cancer	0.0272	0.0337	CbGbCtD
Quinidine—ABCC2—Cisplatin—testicular cancer	0.0249	0.0309	CbGbCtD
Quinidine—CYP2C8—Ifosfamide—testicular cancer	0.0247	0.0306	CbGbCtD
Quinidine—ABCC2—Etoposide—testicular cancer	0.0245	0.0303	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—testicular cancer	0.0195	0.0242	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—testicular cancer	0.0184	0.0228	CbGbCtD
Quinidine—CYP2C9—Ifosfamide—testicular cancer	0.0172	0.0213	CbGbCtD
Quinidine—SLC22A8—Methotrexate—testicular cancer	0.017	0.0211	CbGbCtD
Quinidine—ABCC2—Doxorubicin—testicular cancer	0.0167	0.0207	CbGbCtD
Quinidine—ABCC2—Methotrexate—testicular cancer	0.0162	0.0201	CbGbCtD
Quinidine—CYP2B6—Cisplatin—testicular cancer	0.0158	0.0196	CbGbCtD
Quinidine—CYP2E1—Etoposide—testicular cancer	0.0158	0.0196	CbGbCtD
Quinidine—ABCB1—Dactinomycin—testicular cancer	0.0141	0.0175	CbGbCtD
Quinidine—CYP2C8—Etoposide—testicular cancer	0.0118	0.0146	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—testicular cancer	0.0106	0.0132	CbGbCtD
Quinidine—CYP3A4—Ifosfamide—testicular cancer	0.01	0.0124	CbGbCtD
Quinidine—CYP1A2—Etoposide—testicular cancer	0.00913	0.0113	CbGbCtD
Quinidine—ABCB1—Vinblastine—testicular cancer	0.00886	0.011	CbGbCtD
Quinidine—CYP2C9—Cisplatin—testicular cancer	0.00837	0.0104	CbGbCtD
Quinidine—CYP2D6—Vinblastine—testicular cancer	0.00835	0.0103	CbGbCtD
Quinidine—ABCB1—Cisplatin—testicular cancer	0.00812	0.0101	CbGbCtD
Quinidine—ABCB1—Etoposide—testicular cancer	0.00798	0.00989	CbGbCtD
Quinidine—ABCB1—Doxorubicin—testicular cancer	0.00544	0.00675	CbGbCtD
Quinidine—CYP3A4—Vinblastine—testicular cancer	0.00531	0.00658	CbGbCtD
Quinidine—ABCB1—Methotrexate—testicular cancer	0.00527	0.00654	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—testicular cancer	0.00513	0.00636	CbGbCtD
Quinidine—CYP3A4—Etoposide—testicular cancer	0.00478	0.00593	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—testicular cancer	0.00326	0.00404	CbGbCtD
Quinidine—KCNK6—gonad—testicular cancer	0.00207	0.137	CbGeAlD
Quinidine—KCNK6—testis—testicular cancer	0.00149	0.0991	CbGeAlD
Quinidine—KCNK1—seminal vesicle—testicular cancer	0.00127	0.0843	CbGeAlD
Quinidine—KCNK1—female gonad—testicular cancer	0.000746	0.0495	CbGeAlD
Quinidine—SLC22A4—seminal vesicle—testicular cancer	0.000666	0.0442	CbGeAlD
Quinidine—KCNK1—testis—testicular cancer	0.000662	0.0439	CbGeAlD
Quinidine—ABCB11—testis—testicular cancer	0.000583	0.0387	CbGeAlD
Quinidine—KCNK1—lymph node—testicular cancer	0.00048	0.0318	CbGeAlD
Quinidine—KCNH2—seminal vesicle—testicular cancer	0.000466	0.031	CbGeAlD
Quinidine—SLC22A5—seminal vesicle—testicular cancer	0.000441	0.0293	CbGeAlD
Quinidine—SCN3A—testis—testicular cancer	0.000396	0.0263	CbGeAlD
Quinidine—CYP2E1—seminal vesicle—testicular cancer	0.000359	0.0238	CbGeAlD
Quinidine—SLCO1A2—testis—testicular cancer	0.000318	0.0211	CbGeAlD
Quinidine—ABCC2—testis—testicular cancer	0.000296	0.0197	CbGeAlD
Quinidine—SCN3A—lymph node—testicular cancer	0.000287	0.0191	CbGeAlD
Quinidine—CYP2B6—gonad—testicular cancer	0.000277	0.0184	CbGeAlD
Quinidine—KCNH2—female gonad—testicular cancer	0.000274	0.0182	CbGeAlD
Quinidine—ORM1—lymph node—testicular cancer	0.000261	0.0174	CbGeAlD
Quinidine—SLC22A5—female gonad—testicular cancer	0.000259	0.0172	CbGeAlD
Quinidine—SLC22A4—lymph node—testicular cancer	0.000252	0.0167	CbGeAlD
Quinidine—KCNH2—testis—testicular cancer	0.000243	0.0161	CbGeAlD
Quinidine—CYP1A1—female gonad—testicular cancer	0.000231	0.0154	CbGeAlD
Quinidine—SLC22A5—testis—testicular cancer	0.00023	0.0152	CbGeAlD
Quinidine—CYP2C8—testis—testicular cancer	0.000222	0.0148	CbGeAlD
Quinidine—ABCB1—embryo—testicular cancer	0.000218	0.0145	CbGeAlD
Quinidine—ABCC2—lymph node—testicular cancer	0.000215	0.0143	CbGeAlD
Quinidine—ABCB1—seminal vesicle—testicular cancer	0.000205	0.0136	CbGeAlD
Quinidine—CYP2B6—testis—testicular cancer	0.000199	0.0132	CbGeAlD
Quinidine—Asthma—Epirubicin—testicular cancer	0.000193	0.00108	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—testicular cancer	0.000193	0.00108	CcSEcCtD
Quinidine—Thrombocytopenia—Etoposide—testicular cancer	0.000191	0.00107	CcSEcCtD
Quinidine—Tachycardia—Etoposide—testicular cancer	0.000191	0.00107	CcSEcCtD
Quinidine—Liver function test abnormal—Doxorubicin—testicular cancer	0.000191	0.00107	CcSEcCtD
Quinidine—Dyspnoea—Cisplatin—testicular cancer	0.00019	0.00107	CcSEcCtD
Quinidine—Skin disorder—Etoposide—testicular cancer	0.00019	0.00107	CcSEcCtD
Quinidine—Hyperhidrosis—Etoposide—testicular cancer	0.000189	0.00106	CcSEcCtD
Quinidine—Abdominal pain upper—Doxorubicin—testicular cancer	0.000188	0.00106	CcSEcCtD
Quinidine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000188	0.00106	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—testicular cancer	0.000188	0.00105	CcSEcCtD
Quinidine—Angina pectoris—Epirubicin—testicular cancer	0.000188	0.00105	CcSEcCtD
Quinidine—CYP2E1—testis—testicular cancer	0.000187	0.0124	CbGeAlD
Quinidine—Breast disorder—Doxorubicin—testicular cancer	0.000186	0.00105	CcSEcCtD
Quinidine—Anorexia—Etoposide—testicular cancer	0.000186	0.00105	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000186	0.00104	CcSEcCtD
Quinidine—Decreased appetite—Cisplatin—testicular cancer	0.000186	0.00104	CcSEcCtD
Quinidine—Diarrhoea—Dactinomycin—testicular cancer	0.000185	0.00104	CcSEcCtD
Quinidine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000184	0.00103	CcSEcCtD
Quinidine—Vomiting—Bleomycin—testicular cancer	0.000184	0.00103	CcSEcCtD
Quinidine—Pancytopenia—Epirubicin—testicular cancer	0.000183	0.00103	CcSEcCtD
Quinidine—Hypotension—Etoposide—testicular cancer	0.000183	0.00103	CcSEcCtD
Quinidine—Rash—Bleomycin—testicular cancer	0.000183	0.00102	CcSEcCtD
Quinidine—Dermatitis—Bleomycin—testicular cancer	0.000183	0.00102	CcSEcCtD
Quinidine—Hypersensitivity—Ifosfamide—testicular cancer	0.000182	0.00102	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000182	0.00102	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—testicular cancer	0.000182	0.00102	CcSEcCtD
Quinidine—Renal failure—Methotrexate—testicular cancer	0.000181	0.00101	CcSEcCtD
Quinidine—Neutropenia—Epirubicin—testicular cancer	0.00018	0.00101	CcSEcCtD
Quinidine—Asthma—Doxorubicin—testicular cancer	0.000178	0.001	CcSEcCtD
Quinidine—Asthenia—Ifosfamide—testicular cancer	0.000178	0.000996	CcSEcCtD
Quinidine—KCNH2—lymph node—testicular cancer	0.000176	0.0117	CbGeAlD
Quinidine—Sweating—Methotrexate—testicular cancer	0.000176	0.000988	CcSEcCtD
Quinidine—Photosensitivity reaction—Epirubicin—testicular cancer	0.000176	0.000987	CcSEcCtD
Quinidine—Feeling abnormal—Cisplatin—testicular cancer	0.000176	0.000987	CcSEcCtD
Quinidine—Pruritus—Ifosfamide—testicular cancer	0.000175	0.000983	CcSEcCtD
Quinidine—Dyspnoea—Etoposide—testicular cancer	0.000174	0.000978	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—testicular cancer	0.000174	0.000975	CcSEcCtD
Quinidine—Nausea—Bleomycin—testicular cancer	0.000172	0.000965	CcSEcCtD
Quinidine—Vomiting—Dactinomycin—testicular cancer	0.000172	0.000964	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—testicular cancer	0.000171	0.000961	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00017	0.000956	CcSEcCtD
Quinidine—Rash—Dactinomycin—testicular cancer	0.00017	0.000956	CcSEcCtD
Quinidine—Decreased appetite—Etoposide—testicular cancer	0.00017	0.000954	CcSEcCtD
Quinidine—Diarrhoea—Ifosfamide—testicular cancer	0.000169	0.00095	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—testicular cancer	0.000169	0.00095	CcSEcCtD
Quinidine—Renal failure—Epirubicin—testicular cancer	0.000169	0.000948	CcSEcCtD
Quinidine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000169	0.000947	CcSEcCtD
Quinidine—Body temperature increased—Cisplatin—testicular cancer	0.000169	0.000947	CcSEcCtD
Quinidine—Jaundice—Epirubicin—testicular cancer	0.000168	0.00094	CcSEcCtD
Quinidine—CYP2D6—female gonad—testicular cancer	0.000167	0.0111	CbGeAlD
Quinidine—Neutropenia—Doxorubicin—testicular cancer	0.000167	0.000936	CcSEcCtD
Quinidine—SLC22A5—lymph node—testicular cancer	0.000166	0.011	CbGeAlD
Quinidine—Haemoglobin—Methotrexate—testicular cancer	0.000166	0.00093	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—testicular cancer	0.000165	0.000925	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—testicular cancer	0.000165	0.000925	CcSEcCtD
Quinidine—Sweating—Epirubicin—testicular cancer	0.000165	0.000924	CcSEcCtD
Quinidine—Dizziness—Ifosfamide—testicular cancer	0.000164	0.000918	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—testicular cancer	0.000163	0.000913	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000163	0.000913	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—testicular cancer	0.000162	0.000907	CcSEcCtD
Quinidine—Feeling abnormal—Etoposide—testicular cancer	0.000161	0.000904	CcSEcCtD
Quinidine—Nausea—Dactinomycin—testicular cancer	0.000161	0.0009	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—testicular cancer	0.00016	0.0009	CcSEcCtD
Quinidine—Gastrointestinal pain—Etoposide—testicular cancer	0.00016	0.000897	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—testicular cancer	0.000159	0.000891	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000158	0.000884	CcSEcCtD
Quinidine—Vomiting—Ifosfamide—testicular cancer	0.000157	0.000883	CcSEcCtD
Quinidine—Hypersensitivity—Cisplatin—testicular cancer	0.000157	0.000882	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—testicular cancer	0.000157	0.000881	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—testicular cancer	0.000156	0.000877	CcSEcCtD
Quinidine—Rash—Ifosfamide—testicular cancer	0.000156	0.000876	CcSEcCtD
Quinidine—Dermatitis—Ifosfamide—testicular cancer	0.000156	0.000875	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—testicular cancer	0.000156	0.000874	CcSEcCtD
Quinidine—Urticaria—Etoposide—testicular cancer	0.000155	0.000871	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—testicular cancer	0.000155	0.00087	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—testicular cancer	0.000155	0.00087	CcSEcCtD
Quinidine—Abdominal pain—Etoposide—testicular cancer	0.000155	0.000867	CcSEcCtD
Quinidine—Body temperature increased—Etoposide—testicular cancer	0.000155	0.000867	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—testicular cancer	0.000154	0.000865	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—testicular cancer	0.000154	0.000865	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—testicular cancer	0.000154	0.000864	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—testicular cancer	0.000154	0.000862	CcSEcCtD
Quinidine—Asthenia—Cisplatin—testicular cancer	0.000153	0.000859	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—testicular cancer	0.000153	0.000858	CcSEcCtD
Quinidine—Sweating—Doxorubicin—testicular cancer	0.000152	0.000855	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—testicular cancer	0.000152	0.000855	CcSEcCtD
Quinidine—Urethral disorder—Epirubicin—testicular cancer	0.000151	0.000848	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—testicular cancer	0.000149	0.000835	CcSEcCtD
Quinidine—CYP1A1—lymph node—testicular cancer	0.000149	0.00987	CbGeAlD
Quinidine—Visual impairment—Epirubicin—testicular cancer	0.000149	0.000834	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—testicular cancer	0.000149	0.000833	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—testicular cancer	0.000148	0.000832	CcSEcCtD
Quinidine—CYP2D6—testis—testicular cancer	0.000148	0.00983	CbGeAlD
Quinidine—Chills—Methotrexate—testicular cancer	0.000148	0.00083	CcSEcCtD
Quinidine—ABCB1—gonad—testicular cancer	0.000148	0.00981	CbGeAlD
Quinidine—Nausea—Ifosfamide—testicular cancer	0.000147	0.000825	CcSEcCtD
Quinidine—Diarrhoea—Cisplatin—testicular cancer	0.000146	0.000819	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—testicular cancer	0.000146	0.000818	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—testicular cancer	0.000145	0.000815	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—testicular cancer	0.000144	0.00081	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—testicular cancer	0.000144	0.000809	CcSEcCtD
Quinidine—Hypersensitivity—Etoposide—testicular cancer	0.000144	0.000808	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—testicular cancer	0.000144	0.000807	CcSEcCtD
Quinidine—Erythema—Methotrexate—testicular cancer	0.000144	0.000805	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—testicular cancer	0.000144	0.000805	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—testicular cancer	0.000143	0.000805	CcSEcCtD
Quinidine—Flushing—Epirubicin—testicular cancer	0.000143	0.000803	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—testicular cancer	0.000143	0.000803	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—testicular cancer	0.000143	0.000801	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—testicular cancer	0.000143	0.000801	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000141	0.000791	CcSEcCtD
Quinidine—Asthenia—Etoposide—testicular cancer	0.00014	0.000787	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—testicular cancer	0.00014	0.000785	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—testicular cancer	0.000139	0.000782	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—testicular cancer	0.000139	0.00078	CcSEcCtD
Quinidine—Chills—Epirubicin—testicular cancer	0.000138	0.000777	CcSEcCtD
Quinidine—Pruritus—Etoposide—testicular cancer	0.000138	0.000776	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—testicular cancer	0.000138	0.000772	CcSEcCtD
Quinidine—Vomiting—Cisplatin—testicular cancer	0.000136	0.000761	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—testicular cancer	0.000135	0.000759	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—testicular cancer	0.000135	0.000758	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—testicular cancer	0.000135	0.000757	CcSEcCtD
Quinidine—Rash—Cisplatin—testicular cancer	0.000135	0.000755	CcSEcCtD
Quinidine—Dermatitis—Cisplatin—testicular cancer	0.000134	0.000754	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—testicular cancer	0.000134	0.000753	CcSEcCtD
Quinidine—Erythema—Epirubicin—testicular cancer	0.000134	0.000753	CcSEcCtD
Quinidine—Diarrhoea—Etoposide—testicular cancer	0.000134	0.000751	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—testicular cancer	0.000133	0.000748	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—testicular cancer	0.000133	0.000747	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—testicular cancer	0.000133	0.000743	CcSEcCtD
Quinidine—Flushing—Doxorubicin—testicular cancer	0.000133	0.000743	CcSEcCtD
Quinidine—Dizziness—Etoposide—testicular cancer	0.000129	0.000725	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—testicular cancer	0.000129	0.000723	CcSEcCtD
Quinidine—Vertigo—Methotrexate—testicular cancer	0.000129	0.000723	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000129	0.000722	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—testicular cancer	0.000128	0.000721	CcSEcCtD
Quinidine—Chills—Doxorubicin—testicular cancer	0.000128	0.000719	CcSEcCtD
Quinidine—Nausea—Cisplatin—testicular cancer	0.000127	0.000711	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—testicular cancer	0.000127	0.00071	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—testicular cancer	0.000125	0.000702	CcSEcCtD
Quinidine—Convulsion—Methotrexate—testicular cancer	0.000124	0.000698	CcSEcCtD
Quinidine—Vomiting—Etoposide—testicular cancer	0.000124	0.000697	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—testicular cancer	0.000124	0.000697	CcSEcCtD
Quinidine—Erythema—Doxorubicin—testicular cancer	0.000124	0.000697	CcSEcCtD
Quinidine—Agitation—Epirubicin—testicular cancer	0.000123	0.000692	CcSEcCtD
Quinidine—Rash—Etoposide—testicular cancer	0.000123	0.000692	CcSEcCtD
Quinidine—Dermatitis—Etoposide—testicular cancer	0.000123	0.000691	CcSEcCtD
Quinidine—Headache—Etoposide—testicular cancer	0.000123	0.000687	CcSEcCtD
Quinidine—Chest pain—Methotrexate—testicular cancer	0.000122	0.000685	CcSEcCtD
Quinidine—Myalgia—Methotrexate—testicular cancer	0.000122	0.000685	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000121	0.000681	CcSEcCtD
Quinidine—Vertigo—Epirubicin—testicular cancer	0.000121	0.000677	CcSEcCtD
Quinidine—Syncope—Epirubicin—testicular cancer	0.00012	0.000676	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—testicular cancer	0.00012	0.000674	CcSEcCtD
Quinidine—ABCB1—female gonad—testicular cancer	0.00012	0.00797	CbGeAlD
Quinidine—Palpitations—Epirubicin—testicular cancer	0.000119	0.000666	CcSEcCtD
Quinidine—Confusional state—Methotrexate—testicular cancer	0.000118	0.000663	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—testicular cancer	0.000118	0.000662	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—testicular cancer	0.000117	0.000657	CcSEcCtD
Quinidine—Convulsion—Epirubicin—testicular cancer	0.000116	0.000653	CcSEcCtD
Quinidine—Nausea—Etoposide—testicular cancer	0.000116	0.000652	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—testicular cancer	0.000115	0.000644	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—testicular cancer	0.000115	0.000643	CcSEcCtD
Quinidine—Chest pain—Epirubicin—testicular cancer	0.000114	0.000641	CcSEcCtD
Quinidine—Myalgia—Epirubicin—testicular cancer	0.000114	0.000641	CcSEcCtD
Quinidine—Agitation—Doxorubicin—testicular cancer	0.000114	0.000641	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—testicular cancer	0.000114	0.000638	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000114	0.000637	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000113	0.000635	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—testicular cancer	0.000112	0.000626	CcSEcCtD
Quinidine—Anorexia—Methotrexate—testicular cancer	0.000112	0.000626	CcSEcCtD
Quinidine—Syncope—Doxorubicin—testicular cancer	0.000111	0.000625	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—testicular cancer	0.000111	0.000624	CcSEcCtD
Quinidine—Confusional state—Epirubicin—testicular cancer	0.000111	0.00062	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—testicular cancer	0.00011	0.000616	CcSEcCtD
Quinidine—Oedema—Epirubicin—testicular cancer	0.00011	0.000615	CcSEcCtD
Quinidine—Hypotension—Methotrexate—testicular cancer	0.000109	0.000614	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—testicular cancer	0.000109	0.000613	CcSEcCtD
Quinidine—Shock—Epirubicin—testicular cancer	0.000108	0.000605	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—testicular cancer	0.000108	0.000604	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—testicular cancer	0.000108	0.000603	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—testicular cancer	0.000107	0.000602	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—testicular cancer	0.000107	0.0006	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000107	0.000599	CcSEcCtD
Quinidine—ABCB1—testis—testicular cancer	0.000107	0.00707	CbGeAlD
Quinidine—Skin disorder—Epirubicin—testicular cancer	0.000106	0.000597	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000106	0.000594	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—testicular cancer	0.000106	0.000593	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—testicular cancer	0.000106	0.000593	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000105	0.000589	CcSEcCtD
Quinidine—Anorexia—Epirubicin—testicular cancer	0.000104	0.000586	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—testicular cancer	0.000104	0.000586	CcSEcCtD
Quinidine—Hypotension—Epirubicin—testicular cancer	0.000102	0.000575	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—testicular cancer	0.000102	0.000574	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—testicular cancer	0.000102	0.000571	CcSEcCtD
Quinidine—Oedema—Doxorubicin—testicular cancer	0.000101	0.000569	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000101	0.000567	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.99e-05	0.00056	CcSEcCtD
Quinidine—Shock—Doxorubicin—testicular cancer	9.98e-05	0.00056	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—testicular cancer	9.95e-05	0.000558	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—testicular cancer	9.93e-05	0.000557	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—testicular cancer	9.9e-05	0.000555	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—testicular cancer	9.85e-05	0.000553	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—testicular cancer	9.81e-05	0.00055	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—testicular cancer	9.77e-05	0.000548	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—testicular cancer	9.67e-05	0.000542	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—testicular cancer	9.65e-05	0.000541	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—testicular cancer	9.58e-05	0.000537	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—testicular cancer	9.53e-05	0.000535	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—testicular cancer	9.48e-05	0.000532	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—testicular cancer	9.46e-05	0.000531	CcSEcCtD
Quinidine—Urticaria—Methotrexate—testicular cancer	9.31e-05	0.000522	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—testicular cancer	9.26e-05	0.000519	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—testicular cancer	9.26e-05	0.000519	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.24e-05	0.000518	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—testicular cancer	9.04e-05	0.000507	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—testicular cancer	9.03e-05	0.000507	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—testicular cancer	8.96e-05	0.000503	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—testicular cancer	8.82e-05	0.000495	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.76e-05	0.000491	CcSEcCtD
Quinidine—Urticaria—Epirubicin—testicular cancer	8.71e-05	0.000488	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—testicular cancer	8.67e-05	0.000486	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—testicular cancer	8.67e-05	0.000486	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—testicular cancer	8.63e-05	0.000484	CcSEcCtD
Quinidine—Asthenia—Methotrexate—testicular cancer	8.4e-05	0.000471	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—testicular cancer	8.36e-05	0.000469	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—testicular cancer	8.29e-05	0.000465	CcSEcCtD
Quinidine—Pruritus—Methotrexate—testicular cancer	8.29e-05	0.000465	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—testicular cancer	8.08e-05	0.000453	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—testicular cancer	8.06e-05	0.000452	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—testicular cancer	8.02e-05	0.00045	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—testicular cancer	8.02e-05	0.00045	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—testicular cancer	8.01e-05	0.00045	CcSEcCtD
Quinidine—Asthenia—Epirubicin—testicular cancer	7.87e-05	0.000441	CcSEcCtD
Quinidine—Pruritus—Epirubicin—testicular cancer	7.76e-05	0.000435	CcSEcCtD
Quinidine—Dizziness—Methotrexate—testicular cancer	7.75e-05	0.000434	CcSEcCtD
Quinidine—ABCB1—lymph node—testicular cancer	7.73e-05	0.00513	CbGeAlD
Quinidine—Diarrhoea—Epirubicin—testicular cancer	7.5e-05	0.000421	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—testicular cancer	7.47e-05	0.000419	CcSEcCtD
Quinidine—Vomiting—Methotrexate—testicular cancer	7.45e-05	0.000418	CcSEcCtD
Quinidine—Rash—Methotrexate—testicular cancer	7.39e-05	0.000414	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—testicular cancer	7.38e-05	0.000414	CcSEcCtD
Quinidine—Headache—Methotrexate—testicular cancer	7.34e-05	0.000412	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—testicular cancer	7.28e-05	0.000408	CcSEcCtD
Quinidine—Dizziness—Epirubicin—testicular cancer	7.25e-05	0.000407	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—testicular cancer	7.18e-05	0.000403	CcSEcCtD
Quinidine—Vomiting—Epirubicin—testicular cancer	6.97e-05	0.000391	CcSEcCtD
Quinidine—Nausea—Methotrexate—testicular cancer	6.96e-05	0.00039	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—testicular cancer	6.94e-05	0.000389	CcSEcCtD
Quinidine—Rash—Epirubicin—testicular cancer	6.91e-05	0.000388	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—testicular cancer	6.91e-05	0.000387	CcSEcCtD
Quinidine—Headache—Epirubicin—testicular cancer	6.87e-05	0.000385	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—testicular cancer	6.71e-05	0.000376	CcSEcCtD
Quinidine—Nausea—Epirubicin—testicular cancer	6.51e-05	0.000365	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—testicular cancer	6.45e-05	0.000362	CcSEcCtD
Quinidine—Rash—Doxorubicin—testicular cancer	6.4e-05	0.000359	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—testicular cancer	6.39e-05	0.000358	CcSEcCtD
Quinidine—Headache—Doxorubicin—testicular cancer	6.35e-05	0.000356	CcSEcCtD
Quinidine—Nausea—Doxorubicin—testicular cancer	6.02e-05	0.000338	CcSEcCtD
